Toward Microfluidic Reactors for Cell‐Free Protein Synthesis at the Point‐of‐Care. Issue 6 (22nd December 2015)

• Record Type: Journal Article
• Authors: Timm, Andrea C.; Shankles, Peter G.; Foster, Carmen M.; Doktycz, Mitchel J.; Retterer, Scott T.
• Is Part Of: Small. Volume 12:Issue 6(2016)
• Page Start: 810
• Page End: 817
• Publication Date: 2015-12-22
• Subjects: biologics -- cell‐free protein synthesis -- electron‐beam lithography -- microfluidics -- microreactors; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201502764
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract : Cell‐free protein synthesis (CFPS) is a powerful technology that allows for optimization of protein production without maintenance of a living system. Integrated within micro and nanofluidic architectures, CFPS can be optimized for point‐of‐care use. Here, the development of a microfluidic bioreactor designed to facilitate the production of a single‐dose of a therapeutic protein, in a small footprint device at the point‐of‐care, is described. This new design builds on the use of a long, serpentine channel bioreactor and is enhanced by integrating a nanofabricated membrane to allow exchange of materials between parallel "reactor" and "feeder" channels. This engineered membrane facilitates the exchange of metabolites, energy, and inhibitory species, and can be altered by plasma‐enhanced chemical vapor deposition and atomic layer deposition to tune the exchange rate of small molecules. This allows for extended reaction times and improved yields. Further, the reaction product and higher molecular weight components of the transcription/translation machinery in the reactor channel can be retained. It has been shown that the microscale bioreactor design produces higher protein yields than conventional tube‐based batch formats, and that product yields can be dramatically improved by facilitating small molecule exchange within the dual‐channel bioreactor. Abstract : Methods for the on‐demand synthesis of therapeutic proteins at the point‐of‐care are needed. Here, a dual‐channel, microfluidic exchange bioreactor is described, which is capable of producing therapeutics using cell‐free protein synthesis. These bioreactors are designed to be one part of a modular, fluidic system enabling the synthesis of a purified therapeutic dose at the point‐of‐care.